E-posters and recordings

 

All e-posters and recordings will be available online from 10:00 AM CEST on 19 October 2021.

 

Factors to better understand zoonotic TB among nomadic pastoralists in Northern Nigeria: screening with GeneXpert and evaluation of pulmonary GeneXpert positives with HAIN MTBC testing

E-poster.

KNCV representative:

• Jerod Scholten

 

Robustness of the Simple One-Step (SOS) stool processing method for Xpert MTB/RIF testing: preliminary results from Ethiopia

E-poster.

KNCV representative:

• Petra de Haas

Women “Iddirs” as COVID-19 resilient partners in improving tuberculosis preventive treatment in three zones in Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

Local solutions that helped mitigate the impact of COVID-19 on TB case detection in remote rural zones in southern Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

Accuracy of a new risk scoring tool to identify diabetes mellitus in tuberculosis patients in Addis Ababa, Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

Routine chest x-ray based TB screening and its yield among patients with diabetes mellitus in public health facilities in Addis Ababa, Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

Diabetes mellitus and its predictors among patients with active tuberculosis in Addis Ababa, Ethiopia

E-poster.

KNCV representative:

• Chaltu Muleta

 

Introduction of 3HP nearly doubled the uptake of TPT among PLHIV newly enrolled in ART in Ethiopia

E-poster.

KNCV representative:

• Christiaan Mulder

 

Use of smart pillbox to improve tuberculosis treatment outcomes in Ethiopia: preliminary findings from the run-in phase of the ASCENT project 

E-poster.

KNCV representative:

• Kristian van Kalmthout

 

Improved tuberculosis preventive therapy for contacts during COVID-19 in Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

Impact of COVID-19 on detection of drug-resistant tuberculosis in Ethiopia 

E-poster.

KNCV representative:

• Degu Jerene

 

GeneXpert testing and utilization rates were declined by one-fourth after COVID-19 pandemic in Ethiopia

E-poster.

KNCV representative:

• Degu Jerene

 

Leveraging Family Health Team to and missing people with TB in Underserved Urban Population, Harar, Ethiopia 

Oral abstract.

KNCV representative:

• Degu Jerene

 

Active TB case finding in prison setting: Experience of Harar and East Hararghe correction centers, Harar, Ethiopia

E-poster.

KNCV representative:

• Degu Jerene

 

TB vaccine implementation scenario

E-poster.

KNCV representative:

• Puck Pelzer

 

Clinical trial site directory TB vaccines

E-poster.

KNCV representative:

• Puck Pelzer

 

Modelling the impact and cost-effectiveness of bringing tuberculosis diagnosis for children using stool to the primary care level

Oral abstract.

KNCV representative:

• Edine Tiemersma

 

The First Cohort of Tuberculosis patients on the BPaL Regimen under Operational Research Conditions in Ukraine: Preliminary Results

Oral abstract.

KNCV representative:

• Veriko Mirtskhulava 

 

The other side of the Wellness on Wheels (WoW) truck: A great tool for advocacy and community mobilization

E-poster.

KNCV representative:

• Bethrand Odume

 

The contribution of hospital service delivery points to high tuberculosis yield: the TB –lon experience

E-poster.

KNCV representative:

• Stephanie Gande

 

Key to Finding Missing Childhood Tuberculosis Cases: Think Community, Think Contact Investigation

E-poster.

KNCV representative:

• Victor Falokun

 

Using CAD4TB scores to streamline clinical diagnosis

E-poster.

KNCV representative:

• Mustapha Tukur

 

Improving the effectiveness of hot- spot analytics using the Early Warning Outbreak Recognition System (EWORS); a community level approach

E-poster.

KNCV representative:

• Tobi Nissi

 

Improving TB treatment coverage in Nigeria – Is Public Private Mix (PPM) the missing link?

E-poster.

KNCV representative:

• Sani Useni

 

Best Practices And Challenges Of TB Active Case Finding (TB Surge) In Tertiary Institutions In Nasarawa State, Nigeria

E-poster.

KNCV representative:

• Daniel Egbule

 

Best Practices And Challenges In Community Based Approach To TB Case Finding In Nasarawa State, Nigeria

E-poster.

KNCV representative:

• Daniel Egbule

 

Putting Primary Health facilities at the center of Tuberculosis Case Finding – Lessons from the TB surge intervention in selected PHCs in Akwa Ibom State.

E-poster.

KNCV representative:

• Austin Ihesie

 

Paradigm Shift in Community Outreaches for TB case finding: Health Worker Model Versus Community Based Organization Model in Northern Nigeria

E-poster.

KNCV representative:

• Temidayo Fawole

 

Assessing the contributions of the use of stool-based Xpert test for pediatric TB diagnosis in Nigeria

E-poster.

KNCV representative:

• Nkiru Nwokoye

 

Improving the efficiency of community TB ACF interventions using the EWORS hot spot analytics

E-poster.

KNCV representative:

• Chidubem Ogbudebe

 

Use of digital hotspot to conduct targeted community outreaches in Cross River State

E-poster.

KNCV representative:

• Ifiok Ekanim

 

Medical facility Based TB Case Detection in Anambra, Delta, And Imo State Nigeria: A Six-Month Review

E-poster.

KNCV representative:

• Yekumah Wali

 

Achieving END TB strategy in Nigeria: the role of Health System governance.

E-poster.

KNCV representative:

• Ogoamaka Chukwuogo

 

PPM as a tool for increasing access to TB Services in rural and underserved areas: a case study of Rimi LG, Katsina.

E-poster.

KNCV representative:

• Hauwa Garba Usman

 

Programme: Tuesday, 19 October 2021

11:00 – 12:20: TB: transmission to treatment?

Oral abstract session.

KNCV representative:

• Mustapha Tukur: Report of an Outbreak of Tuberculosis in Kano Central Correctional Center, Kano, Nigeria

 

12:30-13:50: ‘ABCs’ of Scaling up 3HP in Children

Symposium.

KNCV representative:

• Petros Mitiku: Implementation of 3HP and the TPT uptake among child contacts in 73 health facilities in Ethiopia

 

12:30 – 13:50: TPT regimens: safety first

Oral abstract session.

KNCV representative:

• Dawit Assefa: Community volunteers can detect side effects and achieve high TB preventive treatment completion rate among young children exposed to infectious TB cases, in Ethiopia

 

12:30 – 13:50: Quality people-centred TB care 

Oral abstract session.

KNCV representative:

• Stephanie Gande: The positive impact of gender-based intervention on TB case notifications: the case study of Kano State, Nigeria

 

16:30-17:50: Guideline update on rapid molecular diagnostics for extrapulmonary TB: what is new and how far are countries implementing new tools?

Symposium.

KNCV representatives:

• Petra de Haas, chair
• Connie Erkens: Diagnosis of EPTB in a high-income country: a different epidemiological landscape

 

16:30-17:50: TB and COVID-19 transmission dynamics

Oral abstract session.

KNCV representative:

• Puck Pelzer: The impact of COVID-19 on TB epidemiology in six high-burden countries 

Programme: Wednesday, 20 October 2021

09:45-10:45: Nurses and Allied Professionals

Meet the expert session.

KNCV representatives:

• Niesje Jansen: chair, and Psychosocial support for people with TB 

 

12:30-13:50: Strategies to find the missing millions

Oral abstract session.

KNCV representative:

• Ogoamaka Chukwuogo: Strategic approach to the optimisation of TB contact investigation: the KNCV Nigeria experience

 

15:00 – 16:20: Is TB elimination feasible in high TB burden countries in the foreseeable future? Reviewing progress and charting future directions 

Symposium.

KNCV representatives:

• Degu Jerene, chair
• Tefera Agizew: Ethiopia’s consistent decline in TB incidence as a promising trend for setting the stage for TB elimination: Data from the Eliminate TB from Ethiopia project

16:30-17:50: TB digital adherence technologies – implementation lessons from the field

Symposium.

KNCV representative:

• Job van Rest: Planning and implementation of digital adherence technologies; what steps to follow?

 

16:30-17:50: Stakeholder interaction in TB care

Symposium.

KNCV representative:

• Austin Ihesie: Changing the narrative in Low TB reporting Local Government Areas in South-South Nigeria: Is PPM the Game changer?

Programme: Thursday, 21 October 2021

12:30-13:50: Innovation in training and education materials for TB and beyond

Symposium.

KNCV representative:

• Niesje Jansen, chair

16:30 – 17:50: The BPaL regimen: update on clinical and operational research

Symposium.

KNCV representative:

• Agnes Gebhard, chair

 

17:45-18:15: Daily rapporteur 03

Rapporteur.

KNCV representative:

• Niesje Jansen, presenting highlights on behalf of the Nursing and Allied Professionals Subsection.

Programme: Friday, 22 October 2021

11:00-12:20: Innovations in diagnostics

Oral abstract session.

KNCV representative:

• Petra de Haas, moderator
• Edine Tiemersma: Accuracy of the Simple One-step (SOS) stool method with Xpert MTB/RIF Ultra assay for the diagnosis of Mycobacterium tuberculosis in children 

 

12:30-13:50: Ground realities: challenges with Xpert

Oral abstract session.

KNCV representative:

• Kristin Kremer, chair

 

12:30-13:50: Leveraging existing platforms to ensure coordinated and improved diagnostics and care for HIV, TB, HPV and COVID-19

Symposium.

KNCV representatives:

• Degu Jerene, chair
• Ahmed Bedru: Bidirectional screening for TB and diabetes mellitus in Ethiopia as an opportunity for integrating COVID-19 care 

 

15:00-16:30: Occupational health of health workers – WHO Year of the Health Worker

Special session.

KNCV representative:

• Kathy Fiekert: Who cares for the carers? The impact of stigma & COVID-19 on health care workers

 

17:45-18:15: Daily rapporteur 04

Rapporteur.

KNCV representative:

• Niesje Jansen, presenting highlights on behalf of the Nursing and Allied Professionals Subsection.